Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 123.01 Million

CAGR (2023-2028)

5.02%

Fastest Growing Segment

Management Device

Largest Market

Bali





Market Overview

Indonesia Diabetes Care Device Market has valued at USD 123.01 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.02% through 2028. Diabetes care involves a comprehensive approach to managing diabetes, a chronic condition characterized by high blood sugar levels. It includes monitoring blood glucose, maintaining a balanced diet, engaging in regular physical activity, and adhering to prescribed medications or insulin therapy. Regular check-ups, eye exams, and foot care are crucial for early detection of complications. Patient education and self-management are key aspects, empowering individuals to make informed choices about their health. Effective diabetes care aims to achieve stable blood sugar levels, prevent complications, and enhance the overall quality of life for those living with diabetes. The Indonesia Diabetes Care Device Market has been experiencing steady growth due to the increasing prevalence of diabetes in the country. Diabetes has become a significant public health concern, with both type 1 and type 2 diabetes affecting a substantial portion of the population. Key factors contributing to the growth of the diabetes care device market in Indonesia include Rising Diabetes Incidence: Indonesia has one of the highest diabetes prevalence rates in Southeast Asia. The escalating incidence of diabetes drives the demand for monitoring and management devices. Awareness and Education: There is a growing awareness of diabetes and its management, leading to increased adoption of monitoring devices such as blood glucose meters and continuous glucose monitors. Technological Advancements: Ongoing developments in diabetes care technology have led to more advanced and user-friendly devices, improving patient compliance and outcomes. Government Initiatives: The Indonesian government has launched programs to raise awareness about diabetes and improve access to diabetes care devices, particularly for underserved populations. Changing Lifestyles: Urbanization and changing lifestyles have contributed to unhealthy dietary habits and sedentary behavior, leading to a higher diabetes risk. This has driven the need for effective monitoring and management. Expanding Healthcare Infrastructure: Improvements in healthcare infrastructure and access to healthcare services have facilitated the diagnosis and treatment of diabetes. Home Healthcare: The trend toward home healthcare services includes diabetes management at home, with patients using devices for self-monitoring and remote consultations with healthcare professionals. The Indonesia Diabetes Care Device Market includes a range of products such as blood glucose meters, insulin pumps, continuous glucose monitors, and insulin pens. As the burden of diabetes continues to grow, the market is expected to expand further, offering innovative solutions to enhance the lives of individuals living with diabetes and improve their overall health outcomes.

Key Market Drivers

Rising Diabetes Prevalence

The rising diabetes prevalence is a significant driver of the Indonesia Diabetes Care Device Market. Indonesia has been grappling with a diabetes epidemic, experiencing one of the highest diabetes prevalence rates in Southeast Asia. Several key factors contribute to this alarming trend: Changing Lifestyles: Urbanization and shifts in dietary habits have led to more sedentary lifestyles and an increased consumption of processed foods high in sugar and unhealthy fats. These lifestyle changes have contributed to a higher risk of obesity and type 2 diabetes. Genetic Predisposition: Genetic factors also play a role, as some individuals are genetically predisposed to developing diabetes. These genetic tendencies, combined with environmental factors, can increase susceptibility to the disease. Aging Population: The aging population in Indonesia is at a higher risk of developing diabetes. With longer life expectancy, more individuals are reaching an age where diabetes becomes more prevalent. Urbanization: Rapid urbanization in Indonesia has led to changes in daily routines and eating habits. Urban areas often have higher rates of diabetes due to the adoption of less active lifestyles and the availability of convenience foods. Limited Access to Healthcare: In many parts of Indonesia, especially in rural areas, access to healthcare facilities and education about diabetes prevention and management is limited. This lack of access can lead to undiagnosed or poorly managed diabetes cases. Obesity: The obesity rate in Indonesia has been increasing, and obesity is a significant risk factor for type 2 diabetes. The combination of poor dietary choices and sedentary lifestyles contributes to the obesity epidemic. As the prevalence of diabetes continues to rise, there is a growing demand for diabetes care devices in Indonesia. These devices include blood glucose meters, continuous glucose monitors, insulin delivery systems, and associated accessories. The goal is to provide individuals with diabetes the tools they need to monitor their blood sugar levels effectively, manage their condition, and prevent complications. The Indonesia Diabetes Care Device Market is expected to remain robust as it strives to address the challenges posed by the increasing diabetes burden in the country.

Technological Advancements

Technological advancements have significantly influenced the Indonesia Diabetes Care Device Market, transforming the landscape of diabetes management. These innovations have provided individuals with diabetes access to more effective, user-friendly, and convenient devices for monitoring and controlling their condition. Some notable technological advancements in the market include: Continuous Glucose Monitoring (CGM): CGM systems use tiny sensors placed under the skin to continuously measure glucose levels, providing real-time data to users. These systems have become more accurate, offering more precise insights into glucose fluctuations, helping individuals make better treatment decisions. Smart Insulin Pens: Smart insulin pens have emerged, allowing users to dose insulin more accurately and track their injections digitally. These pens often sync with mobile apps, helping users monitor their insulin usage and adherence. Mobile Apps and Connectivity: Mobile applications are increasingly integrated with diabetes care devices. Users can track glucose levels, log meals, and receive medication reminders on their smartphones. These apps often provide data analytics and shareable reports to facilitate communication with healthcare providers. Artificial Pancreas Systems: Advanced systems like closed-loop or artificial pancreas systems automatically adjust insulin delivery based on real-time glucose data, reducing the burden of constant monitoring and decision-making for users. Telemedicine Integration: Telemedicine services have become more accessible, allowing individuals to remotely consult with healthcare professionals for diabetes management advice, prescription adjustments, and guidance on device usage. Wearable Devices: Wearable devices, such as smartwatches and fitness trackers, now include health monitoring features like continuous glucose tracking. These devices offer a more holistic approach to health management for individuals with diabetes. Data Integration and Sharing: Interoperability between different devices and electronic health records is improving, making it easier for individuals to share their diabetes data with healthcare providers for more informed decision-making. These technological advancements in diabetes care devices have the potential to enhance the quality of life for individuals with diabetes in Indonesia. They empower users to better understand and manage their condition, reduce the risk of complications, and improve overall health outcomes. As technology continues to evolve, the Indonesia Diabetes Care Device Market is likely to see further innovation, leading to more effective and patient-centered solutions for diabetes management.

Government Initiatives

Government initiatives have played a crucial role in shaping the Indonesia Diabetes Care Device Market. The Indonesian government recognizes the growing diabetes epidemic and the need for comprehensive strategies to manage the disease. Several key initiatives have been launched to address diabetes-related challenges: Public Awareness Campaigns: The government has implemented public awareness campaigns to educate the population about diabetes prevention, early detection, and management. These campaigns emphasize the importance of a healthy lifestyle and regular check-ups. Healthcare Infrastructure Development: Investments have been made in expanding healthcare infrastructure, including the availability of healthcare facilities and clinics in both urban and rural areas. This helps in the early diagnosis and treatment of diabetes. Diabetes Screening Programs: The government has initiated diabetes screening programs in communities and healthcare centers, enabling early detection of the disease. This facilitates timely intervention and management. Subsidized Healthcare: Some government programs provide subsidies and financial assistance to individuals with diabetes, making diabetes care devices and medications more affordable and accessible. Telehealth and Telemedicine Support: The government has promoted telehealth and telemedicine services, which are especially important during the COVID-19 pandemic. This enables individuals with diabetes to consult healthcare professionals remotely, reducing the need for in-person visits. Regulatory Framework: The government has worked on creating a regulatory framework to ensure the safety and efficacy of diabetes care devices available in the market. This boosts consumer confidence in these devices. Collaboration with NGOs: Collaborations between the government and non-governmental organizations (NGOs) focus on diabetes prevention, care, and support programs. These partnerships extend the reach of diabetes care initiatives. Diabetes Education: Educational programs for healthcare professionals, patients, and the general public are organized to enhance knowledge about diabetes management and the proper use of diabetes care devices. Government initiatives in Indonesia are pivotal in addressing the diabetes epidemic and promoting a holistic approach to diabetes care. These efforts not only create a more favorable environment for diabetes care device manufacturers and suppliers but also improve the overall health and well-being of individuals living with diabetes in the country.

 

Download Free Sample Report

Key Market Challenges

Lack of Access in Rural Areas

The lack of access to diabetes care devices in rural areas poses a significant challenge in the Indonesia Diabetes Care Device Market. Several factors contribute to this issue: Geographic Barriers: Indonesia's vast and geographically diverse landscape presents logistical challenges for distributing healthcare resources, including diabetes care devices. Remote and rural areas often lack the infrastructure and transportation networks needed to deliver these devices promptly. Healthcare Facilities: Rural regions have fewer healthcare facilities and clinics equipped to diagnose and manage diabetes. These facilities may not stock a wide range of diabetes care devices or have trained professionals to assist patients effectively. Limited Awareness: There is often limited awareness of diabetes and the importance of monitoring and managing the condition in rural communities. Lack of awareness can lead to delayed diagnosis and treatment, with individuals unaware of the role of diabetes care devices in their health. Economic Constraints: Rural populations in Indonesia frequently face economic constraints, which can hinder their ability to afford diabetes care devices. Many individuals may prioritize basic needs over investing in these devices, particularly if they are not fully aware of their benefits. Health Workforce Shortages: Rural areas often experience shortages of healthcare professionals, including doctors and nurses. This shortage can limit access to diabetes care expertise and guidance on device usage. Addressing the lack of access to diabetes care devices in rural areas requires a comprehensive approach. Initiatives include: Mobile Clinics: Mobile clinics and outreach programs can bring diabetes care services, including device distribution and education, directly to rural communities. Health Worker Training: Training local healthcare workers in rural areas to assist with diabetes management and the use of devices can enhance access to care. Telehealth Solutions: Telehealth and telemedicine platforms can connect rural patients with diabetes specialists in urban areas, allowing remote consultations and guidance on device usage. Community Awareness Campaigns: Community-based awareness campaigns can educate rural populations about diabetes, its management, and the benefits of diabetes care devices. Subsidies and Financial Assistance: Government and non-governmental organizations can provide subsidies or financial assistance to make diabetes care devices more affordable for rural populations. By addressing these challenges and implementing targeted interventions, it is possible to improve access to diabetes care devices and services in rural areas of Indonesia, ultimately enhancing the management and outcomes of diabetes in these underserved communities.

Healthcare Workforce Training

Healthcare workforce training plays a critical role in the Indonesia Diabetes Care Device Market, ensuring that healthcare professionals are equipped with the knowledge and skills to effectively use and recommend diabetes care devices. This training is essential for several reasons: Device Proficiency: Healthcare professionals need training to understand how various diabetes care devices work, from blood glucose meters to insulin pumps and continuous glucose monitors. Proficiency in device operation ensures accurate readings and effective device utilization. Interpretation of Data: Diabetes care devices generate vast amounts of data, including blood glucose readings and trends. Training helps healthcare providers interpret this data, allowing them to make informed decisions regarding medication adjustments, treatment plans, and lifestyle recommendations. Patient Education: Healthcare professionals play a crucial role in educating individuals with diabetes about the proper use of care devices. They must convey information on device operation, self-monitoring, and the significance of device data in managing the disease. Individualized Care Plans: Training enables healthcare professionals to develop individualized diabetes care plans tailored to each patient's needs. These plans may include recommendations for specific devices and monitoring schedules. Emergency Response: In the event of diabetes-related emergencies, such as hypoglycemia or hyperglycemia, healthcare providers must be trained to respond promptly and effectively. This training can save lives and prevent complications. Telemedicine Competency: With the increasing adoption of telehealth and remote monitoring, healthcare professionals need training in virtual care delivery and the use of technology to support diabetes management. Quality Assurance: Training programs often include quality assurance measures to ensure that healthcare professionals adhere to established standards of care and use devices correctly, reducing the risk of errors and complications. Cultural Competence: Healthcare professionals may require cultural competence training to effectively communicate with diverse patient populations, recognizing that cultural beliefs and practices can influence diabetes management decisions. In Indonesia, where the diabetes burden is significant, training programs are vital for healthcare providers across the spectrum, including doctors, nurses, pharmacists, and community health workers. These programs should be ongoing, keeping healthcare professionals updated on the latest advancements in diabetes care and device technology. Ultimately, well-trained healthcare professionals are essential in delivering quality diabetes care, promoting positive patient outcomes, and ensuring the effective utilization of diabetes care devices in the country.

Key Market Trends

Telehealth Integration

The integration of telehealth in the Indonesia Diabetes Care Device Market is transforming the landscape of diabetes management by leveraging technology to provide remote healthcare services and support. This integration is particularly valuable in a country as geographically diverse as Indonesia, where access to specialized healthcare can be challenging, especially for individuals with diabetes. Here's how telehealth integration is making a significant impact: Remote Consultations: Telehealth platforms allow individuals with diabetes to consult with healthcare professionals, including endocrinologists, diabetes educators, and dietitians, from the comfort of their homes. This reduces the need for lengthy and often costly travel to healthcare facilities. Real-Time Monitoring: Diabetes care devices, such as continuous glucose monitors (CGMs), can be integrated with telehealth systems. This enables real-time monitoring of blood glucose levels and data sharing with healthcare providers, who can then make timely adjustments to treatment plans. Medication Management: Telehealth consultations facilitate medication management, including insulin dosing adjustments. Healthcare professionals can guide patients on insulin regimens and help prevent over- or under-dosing, which is critical for diabetes management. Education and Support: Telehealth platforms offer educational resources and support for individuals with diabetes. They can receive guidance on dietary choices, exercise routines, and lifestyle modifications to better manage their condition. Remote Device Training: Patients can receive remote training on the proper use of diabetes care devices, ensuring that they can effectively self-monitor and interpret device data. Emergency Response: Telehealth services provide access to emergency assistance in case of diabetes-related emergencies, helping patients and their caregivers respond promptly to critical situations. Reduced Healthcare Costs: Telehealth can potentially reduce healthcare costs by minimizing the need for frequent in-person visits and hospitalizations, making diabetes management more affordable for patients. Rural and Underserved Communities: Telehealth bridges the healthcare gap in rural and underserved areas, where access to specialized diabetes care may be limited. It extends quality care to regions with fewer healthcare facilities. COVID-19 Resilience: Telehealth became even more critical during the COVID-19 pandemic, reducing the risk of virus transmission through in-person visits while ensuring that individuals with diabetes continued to receive necessary care. Data Privacy: As telehealth involves the transmission of sensitive health data, ensuring data privacy and security is a paramount concern, necessitating robust encryption and compliance with data protection regulations. The integration of telehealth in the Indonesia Diabetes Care Device Market not only enhances access to care but also improves patient engagement and the overall quality of diabetes management. It is a powerful tool in addressing the unique healthcare challenges posed by diabetes in the country.

Wearable Diabetes Devices

Wearable diabetes devices are revolutionizing diabetes management in the Indonesia Diabetes Care Device Market by offering individuals with diabetes a more convenient and proactive approach to monitoring their condition. These devices are designed to be worn on the body and provide real-time data and insights, empowering users to make informed decisions about their diabetes care. Here's an overview of wearable diabetes devices and their impact: Continuous Glucose Monitors (CGMs): CGMs are wearable devices that continuously measure glucose levels through a tiny sensor inserted under the skin. They provide real-time data on blood glucose trends, allowing users to track fluctuations throughout the day and night. CGMs are particularly valuable for detecting hypoglycemia and hyperglycemia episodes, helping individuals with diabetes make timely adjustments to their treatment plans. Insulin Pumps: Insulin pumps are wearable devices that deliver a continuous supply of insulin to the body via a small tube or cannula inserted under the skin. Users can program the pump to provide basal insulin doses and deliver bolus doses before meals. These pumps offer precise insulin delivery and the flexibility to adjust insulin doses as needed. Smartwatches and Fitness Trackers: Many smartwatches and fitness trackers now include health monitoring features, including the ability to track glucose levels, physical activity, and sleep patterns. These devices provide a holistic approach to health management for individuals with diabetes. Wearable Apps: Mobile apps compatible with wearable devices allow users to monitor their blood glucose levels, log meals, and track insulin dosing. These apps often provide data analytics, allowing users to identify trends and patterns in their diabetes management. Remote Monitoring: Wearable diabetes devices can be integrated with telehealth platforms, allowing healthcare providers to remotely monitor their patients' glucose levels and treatment adherence. This enables timely interventions and adjustments to treatment plans. User-Friendly Design: Wearable devices are designed to be user-friendly, reducing the burden of diabetes management. They offer convenience and discretion, allowing users to lead more active and fulfilling lives. Empowerment and Engagement: Wearable devices empower individuals with diabetes to take an active role in managing their condition. They promote self-awareness and engagement, ultimately leading to better diabetes control and quality of life. In Indonesia, where diabetes is a significant public health concern, wearable diabetes devices offer a valuable solution to improve diabetes management. They provide real-time data, encourage proactive decision-making, and enhance the overall quality of care for individuals with diabetes, ultimately reducing the risk of complications and improving long-term health outcomes.


Segmental Insights


Monitoring Devices Insights

In 2022, the Diabetes Care Device Market was dominated by the Self-monitoring Blood Glucose Devices segment and is predicted to continue expanding over the coming years. This is attributed due increasing growth in the coming years due to the rising demand for diabetes care devices in the country.

Management Devices Insights

In 2022, the Diabetes Care Device Market was dominated by Insulin Pump segment and is predicted to continue expanding over the coming years. This is due to increasing demand for diabetes care for elderly and chronically ill patients, as well as the growing awareness for the ease.

Download Free Sample Report

Regional Insights

Bali region accounted for the largest revenue share in 2022. This is ascribed due to advanced healthcare infrastructure, stringent regulatory environment, emphasis on patient safety and quality of care, and the presence of key players. 

Recent Developments

In February 2022, Indonesia’s Ministry of Health launched a sectoral e-Katalog for medical devices. Previously, e-Katalog was managed by LKPP, referred to as the national e-Katalog, for all products procured by government institutions street lighting to pacemakers. LKPP e-Katalog is now split into a national e-Katalog for items required nationally and sectoral e-Katalogs, specific to ministries such as the Ministry of Health.

In July 2021, EOFlow said it has agreed to export 45.3 billion won ($38.5 million) worth of its EOPatch, its wearable insulin pump, to PT. Prasasti Nusantara Sukses (PT. PNS) is an Indonesian medical device company.

Key Market Players

  • PT. Becton, Dickinson Indonesia
  • Medtronic
  • Tandem
  • Sanofi
  • PT Eli Lilly Indonesia
  • PT Abbott Indonesia
  • Roche
  • PT Johnson & Johnson Indonesia
  • Dexcom, Inc.
  • PT Novo Nordisk Indonesia

 

By Monitoring Devices

 

By Management Devices

 

 

By Region

  • Self-monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring
  • Insulin Pump
  • Insulin Syringe
  • Insulin Cartridges
  • Disposable Pens
  • Bali
  • Java
  • Kalimantan
  • Sumatra

 

Report Scope:

In this report, the Indonesia Diabetes Care Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

·         Indonesia Diabetes Care Device Market, By Monitoring Devices:

o   Self-monitoring Blood Glucose Devices

o   Continuous Blood Glucose Monitoring

·         Indonesia Diabetes Care Device Market, By Management Devices:

o   Insulin Pump

o   Insulin Syringe

o   Insulin Cartridges

o   Disposable Pens

·         Indonesia Diabetes Care Device Market, By Region:

o   Bali

o   Java

o   Kalimantan

o   Sumatra

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Indonesia Diabetes Care Device Market.

Available Customizations:

Indonesia Diabetes Care Device Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

·         Detailed analysis and profiling of additional market players (up to five).

Indonesia Diabetes Care Device Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]               

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Indonesia Diabetes Care Device Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Monitoring Devices (Self-monitoring Blood Glucose Devices, Continuous Blood Glucose Monitoring)

5.2.1.1.         By Self-monitoring Blood Glucose Devices (Glucometer Devices, Test Strips, Lancet)

5.2.1.2.         By Continuous Blood Glucose Monitoring (Sensor, Durables)

5.2.2.     By Management Devices (Insulin Pump, Insulin Syringe, Insulin Cartridges, Disposable Pens)

5.2.2.1.         By Insulin Pump (Insulin Pump Device, Insulin Pump Reservoir, Infusion Set)

5.2.3.     By Region (Bali, Java, Kalimantan, Sumatra)

5.2.4.     By Company (2022)

5.3.  Product Market Map

5.3.1.     By Monitoring Devices

5.3.2.     By Management Devices

5.3.3.     By Region

6.    Bali Diabetes Care Device Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Monitoring Devices

6.2.2.     By Management Devices

7.    Java Diabetes Care Device Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Monitoring Devices

7.2.2.     By Management Devices

8.    Kalimantan Diabetes Care Device Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Monitoring Devices

8.2.2.     By Management Devices

9.    Sumatra Diabetes Care Device Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Monitoring Devices

9.2.2.     By Management Devices

10.  Market Dynamics

10.1.              Drivers

10.2.              Challenges

11.  Market Trends & Developments

11.1.              Merger & Acquisition

11.2.              Product Development

11.3.              Recent Developments

12.  Policy & Regulatory Landscape

13.  Indonesia Economic Profile

14.  Competitive Landscape

14.1.              Business Overview

14.2.              Company Snapshot

14.3.              Products & Services

14.4.              Financials (As Reported)

14.5.              Recent Developments

14.5.1.  PT. Becton, Dickinson Indonesia

14.5.2.  Medtronic

14.5.3.  Tandem

14.5.4.  Sanofi

14.5.5.  PT Eli Lilly Indonesia

14.5.6.  PT Abbott Indonesia

14.5.7.  Roche

14.5.8.  PT Johnson & Johnson Indonesia

14.5.9.  Dexcom, Inc.

14.5.10.                PT Novo Nordisk Indonesia

15.  Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Indonesia Diabetes Care Device Market was estimated to be USD 123.01 Million in 2022.

down-arrow

PT. Becton, Dickinson Indonesia, Medtronic, Tandem, Sanofi, PT Eli Lilly Indonesia PT Abbott Indonesia, Roche, PT Johnson & Johnson Indonesia, Dexcom, Inc., PT Novo Nordisk Indonesia etc are some of the key players operating in the Indonesia Diabetes Care Device Market.

down-arrow

The cost of diabetes care devices can be prohibitive for many Indonesians, particularly those without health insurance or with limited financial resources. Ensuring affordability is a critical challenge are some of the major challenges faced by the Indonesia Diabetes Care Device Market in the upcoming years.

down-arrow

Increasing awareness about diabetes and its complications has led to higher adoption of monitoring devices, as individuals seek better control of their condition are majorly driving the growth of the Indonesia Diabetes Care Device Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Indonesia Diabetes Care Device Market to Grow with a CAGR of 5.02%through 2028

Jan, 2024

Rising prevalence of diabetes is expected to drive the Indonesia Diabetes Care Device Market in the forecast period 2024-2028.